Prostate cancer (PCa) is the most common malignancy in men of middle and older age. The
standard treatment strategy for PCa ranges from active surveillance in low-grade, localized …

Prostate cancer (PCa) is the second most frequently diagnosed cancer in men. Despite the
significant progress in cancer diagnosis and treatment over the last few years, the approach …

In the VISION trial,[177Lu] Lu-PSMA-617 (177Lu-PSMA-617) plus protocol-permitted
standard of care significantly improved overall survival and radiographic progression-free …

Renal cell carcinoma (RCC) is one of the most commonly diagnosed cancers in the United
States. It accounts for approximately 4.0% of new cancers and 2.3% of cancer-specific …

In recent years, a paradigm shift from single-photon-emitting radionuclide radiotracers
toward positron-emission tomography (PET) radiotracers has occurred in nuclear oncology …

Introduction Venous tumor thrombus (TT) occurs as part of the natural history of renal cell
carcinoma (RCC) local progression in a small minority of cases. MRI is currently the most …

Background Accurate primary staging of renal cancer with conventional imaging is
challenging. Prostate-specific membrane antigen (PSMA) positron emission …

Prostate specific membrane antigen (PSMA) is an emerging diagnostic and therapeutic
target in prostate cancer. 68 Ga-PSMA-labeled hybrid imaging is used for the detection of …

Simple Summary Prostate-specific membrane antigen (PSMA) positron emission
tomography-computed tomography (PET-CT) is an essential imaging tool that is used to …

Accurate classification of well-differentiated hepatocellular neoplasms can be challenging
especially in core biopsies. Prostate-specific membrane antigen (PSMA) has been shown to …